NF2 and plexiform neurofibroma: Clinical criteria were established for NF1 and NF2 in 1987 and for schwannomatosis in 2005.[5], [6] These patients share a predisposition to developing benign nerve sheath tumors, including neurofibromas and schwannomas, that are derived from neoplastic Schwann cells.